Authors
Loading...
Japanese REACH data may guide localized risk stratification; leaves open optimal treatment differences versus global cohorts.
Key points are not available for this paper at this time.
Yamazaki et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: